Product Information

QC IBUPROFEN 200 MG TABLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.0336 per EA under NDC 83324010050. Its NADAC has been published 72 times since Jul 2, 2025.

FDA first approved this application on Oct 7, 2016.

QC IBUPROFEN 200 MG TABLET

Ibuprofen
$0.0336per EA
OTC

Strength

200 mg/1

NDC

83324010050

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA202312

FDA Approved

10/7/2016

On Market Since

5/15/2025

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for QC IBUPROFEN 200 MG TABLET has been published 72 times since Jul 2, 2025, and over the history we have for it it has risen 2.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0336 per EA
All-time high$0.0370 (Nov 12, 2025)
All-time low$0.0320 (Jun 17, 2026)
52-week high$0.0364
52-week low$0.0320
Median price$0.0331
Average price$0.0338
Largest weekly change-5.2% (Dec 17, 2025)
Weeks tracked72
Tracking sinceJul 2, 2025

Price History

1W

0.0%

1M

+1.5%

3M

+4.4%

6M

+4.2%

1Y

-9.0%

3Y

N/A

5Y

N/A

All

+2.3%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of QC IBUPROFEN 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for QC IBUPROFEN 200 MG TABLET, manufactured by Chain Drug Marketing Association, is $0.0336 per EA (NDC 83324010050), effective Nov 11, 2026.

How has the price of QC IBUPROFEN 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for QC IBUPROFEN 200 MG TABLET has risen 2.3%. It has been tracked across 72 weekly CMS publications since Jul 2, 2025.

What are the highest and lowest recorded NADAC prices for QC IBUPROFEN 200 MG TABLET?

Since Jul 2, 2025, the NADAC for QC IBUPROFEN 200 MG TABLET has ranged from a low of $0.0320 (Jun 17, 2026) to a high of $0.0370 (Nov 12, 2025), with a median of $0.0331 per EA.

Are there cheaper alternatives to QC IBUPROFEN 200 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 200 MG TABLET, is $0.0269 per EA — about 20% below QC IBUPROFEN 200 MG TABLET.

Who manufactures QC IBUPROFEN 200 MG TABLET?

QC IBUPROFEN 200 MG TABLET (NDC 83324010050) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.